Global

Pregnancy complications demand long-term cardiovascular care

MENA’s cardiometabolic crisis is a stability issue

For Pompe Infants, Time Is the Comparator

The Most Preventable Cause of Vision Loss May Still Be Smoking

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach

Deep learning uncovers a new ECG biomarker for sudden cardiac death

Half of CKM patients go untreated and most fail control

The Trial Has Started. Now the System Has to Find the Children.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
